Follow us on Twitter
twitter icon@FreshPatents


Blood patents

      

This page is updated frequently with new Blood-related patent applications.

SALE: 1000+ Blood-related patent PDFs



 Subcutaneous outpatient management patent thumbnailSubcutaneous outpatient management
A method of administering insulin includes receiving scheduled blood glucose time intervals and obtaining blood glucose data of a patient that includes blood glucose measurements, blood glucose times, and insulin dosages previously administered by the patient. The method also includes applying a set of filters to identify which of the blood glucose measurements associated with at least one of the scheduled time intervals are usable and which of the blood glucose measurements associated with the at least one scheduled time interval are unusable.
Aseko, Inc.


 Photonic blood typing patent thumbnailPhotonic blood typing
Photonic devices, systems, and methods for detecting an analyte in a biological solution (e.g., whole blood) are provided. Representative photonic devices are optical ring resonators having nanoscale features and micron-sized diameters.
Puget Sound Blood Center


 Diagnostic devices, systems, and methods patent thumbnailDiagnostic devices, systems, and methods
Diagnostic systems, methods, and devices employing low-cost handheld components are disclosed herein. A diagnostic system can include a diagnostic device that is configured to perform one or more assays on a fluid sample, such as a whole blood sample, in one or more microfluidic channels or chambers.
The Trustees Of Columbia University In The City Of New York


 Biomarker compositions specific to coronary heart disease patients and uses thereof patent thumbnailBiomarker compositions specific to coronary heart disease patients and uses thereof
The present invention relates to a disease-specific metabolite profile, and particularly to a biomarker composition obtained by screening from blood plasma-specific profiles of coronary heart disease subjects. The present invention also relates to a use of the biomarker compositions in risk assessment, diagnosis, early diagnosis, or pathological staging of coronary heart disease, and to a method for risk assessment, diagnosis, early diagnosis, or pathological staging of coronary heart disease.
Bgi Shenzhen


 Analyte  determining hemoglobin parameters in whole blood patent thumbnailAnalyte determining hemoglobin parameters in whole blood
A system of measuring hemoglobin and bilirubin parameters in a whole blood sample using optical absorbance. The system includes an optical-sample module, a spectrometer module, an optical fiber module optically connecting the optical-sample module to the spectrometer module, and a processor module.
Nova Biomedical Corporation


 Biochips to diagnose hemoglobin disorders and monitor blood cells patent thumbnailBiochips to diagnose hemoglobin disorders and monitor blood cells
A biochip compatible with very small blood sample volumes is used for delecting for detecting hemoglobin disorders and monitoring disorders associated with aberrant blood cell deformability and adhesion, including disease severity, upcoming pain crisis, treatment response, and treatment effectiveness in a clinically meaningful way.. .
Case Western Reserve University


 Insulinotropic peptide derivative with modified n-terminal charge patent thumbnailInsulinotropic peptide derivative with modified n-terminal charge
The present invention relates to an insulinotropic peptide derivative with a modified n-terminal charge and a pharmaceutical composition including the same. Specifically, the insulinotropic peptide derivative is characterized in that the n-terminal positive charge of the insulinotropic peptide is modified to a neutral or net negative charge at neutral ph.
Hanmi Pharm. Co., Ltd.


 Heterocycle-substituted pyridyl benzothiophenes as kinase inhibitors patent thumbnailHeterocycle-substituted pyridyl benzothiophenes as kinase inhibitors
Or a pharmaceutically acceptable salt thereof, wherein r1, r2, r3, r4 and x are as defined herein. The compounds of formula i are useful as receptor tyrosine kinase (rtk) inhibitors and can be used to treat such diseases as cancer, blood vessel proliferative disorders, fibrotic disorders, mesangial cell proliferative disorders and metabolic diseases..

 Optical monitoring system for blood processing system patent thumbnailOptical monitoring system for blood processing system
An optical monitoring system is provided for use with a blood processing system. The system includes a light source configured to illuminate a disposable flow circuit received in a centrifuge and a light detector configured to receive an image of the disposable flow circuit.
Fenwal, Inc.


 Platelet-targeted microfluidic isolation of cells patent thumbnailPlatelet-targeted microfluidic isolation of cells
Methods and systems for isolating platelet-associated nucleated target cells, e.g., such as circulating epithelial cells, circulating tumor cells (ctcs), circulating endothelial cells (cecs), circulating stem cells (cscs), neutrophils, and macrophages, from sample fluids, e.g., biological fluids, such as blood, bone marrow, plural effusions, and ascites fluid, are described. The methods include obtaining a cell capture chamber including a plurality of binding moieties bound to one or more walls of the chamber, wherein the binding moieties specifically bind to platelets; flowing the sample fluid through the cell capture chamber under conditions that allow the binding moieties to bind to any platelet-associated nucleated target cells in the sample to form complexes; and separating and collecting platelet-associated nucleated target cells from the complexes..
The General Hospital Corporation


Information processing device, information processing method, and program

[object] to provide an information processing device capable of accurately calculating a moving distance on the basis of the number of steps. [solution] the information processing device includes: a movement determination unit configured to determine whether or not a user is moving on the basis of at least one of a heart rate, a blood pressure, and a respiratory rate of the user; and a distance calculation unit configured to calculate a moving distance of the user on the basis of the number of steps of the user in a period in which the movement determination unit determines that the user is moving..
Sony Corporation

Exercise training system

A training system, kit, and method including a weighted wearable equipment, e.g. Gloves, having a sensor (e.g.

Needle and guidewire holder

Device and method for puncturing blood vessels while using fluoroscopy. The disclosed device enables improved needle orientation control and avoids direct exposure of the clinician's hand to x-ray during the puncturing procedure..
The Spectranetics Corporation

Assembly with a guide wire and a fixator for attaching to a blood vessel

A fixator assembly comprising a fixator for fixing inside a blood vessel, the fixator being able to slide proximally along a guide wire. The assembly comprising means for preventing the fixator from moving distally of the preventing means.
Endovascular Development Ab

System and/or glucose sensor calibration

The subject matter disclosed herein relates to systems, methods and/or devices for calibrating sensor data to be used in estimating a blood glucose concentration. A relationship between sensor measurements and reference readings may be used to estimate a relationship between sensor measurements and blood glucose concentration.
Medtronic Minimed, Inc.

Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like

Systems and methods for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and treating hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, attention deficit disorder and nicotine addiction involve synchronizing and tailoring the administration of nutraceuticals, medications and other substances in accordance with the body's natural circadian rhythms, meal times and other factors. Improved control of blood glucose levels, extended alertness, and weight control, and counteracting of disease symptoms when they are at their worst are possible.

Blood circulation system

An artificial heart and lung apparatus includes a roller pump; a blood removal line; a first blood transfer line; a blood removal rate sensor; a control unit that performs the linked control of the roller pump in correspondence with a blood removal rate; and a blood transfer rate adjustment unit that instructs the roller pump to transfer a blood transfer rate. The blood transfer rate adjustment unit includes an operation amount input unit to which an operation amount from an arbitrary circumferential position can be input, and which outputs a pulse signal according to the input operation amount.
Senko Medical Instrument Mfg. Co., Ltd.

Method for using supplemental vascular endothelial growth factor (vegf) or analog to prevent oxygen induced arrest of vessel growth and disease sequela of premature infant birth

Disclosed herein is a method for administering systemic (e.g., by intravenous injection) supplemental vascular endothelial growth factor (vegf) to premature infants to prevent the disease sequelae and complications including but not limited to retinopathy of prematurity (rop) and/or paraventricular leukomalacia (pvl) and/or bronchopulmonary dysplasia (bpd) associated with premature births. The vegf is administered to the premature infant to produce a physiologic serum vegf level that is substantially similar to the vegf level found in a normally developing fetus in the utero.

Oxytocin treatment to improve memory and modify blood glucose

The disclosure provides a method for enhancing memory of a subject, lowering blood glucose levels in a subject, and treating schizophrenia, the methods comprise intranasally administering to the subject an amount of a oxytocin peptide or analogue thereof having a beneficial effect.. .
The Regents Of The University Of California

Method of ameliorating uremia

A method of ameliorating symptoms of uremia includes administering a therapeutic agent including beraprost or each isomer constituting beraprost, or a salt thereof as an effective ingredient to an animal belonging to the family canidae, wherein an effective dosage is a dosage that does not significantly lower blood pressure.. .
Toray Industries, Inc.

Bandage for applying arterial pressure

A hemostasis device comprises a panel having a top side and a bottom side having an adhesive layer coupled to the panel. A button, having a 3-dimensional shape, is integrally molded to the top side of the panel.

Endovascular device for entrapment of participate matter and use

A method for filtering particulate matter from a blood vessel in a patient, including inserting a device into the blood vessel, the device including at least an outer structure capable of insertion into the blood vessel; and an inner filter anchored to the outer structure, the inner filter having a one-way valve though which a medical instrument may be passed.. .
Keystone Heart Ltd.

Thrombectomy filter and performing a thrombectomy

A vascular filter system and method are disclosed. In one embodiment, the filter system comprises a dispensing needle, a guidewire and a catheter releasably attached to a filter dispenser which stores a length of filter wire.

Radiofrequency ablation catheter having meshed tubular stent structure and an apparatus thereof

A radiofrequency ablation catheter having a meshed tubular stent structure and an apparatus thereof, include a meshed tubular stent disposed at a front end of the catheter. The meshed tubular stent comprises and including a meshed tube (1).
Shanghai Golden Leaf Med Tec Co., Ltd.

Axial lengthening thrombus capture system

Disclosed herein are systems and methods to remove material of interest, including blood clots, from a body region, including but not limited to the circulatory system for the treatment of pulmonary embolism (pe), deep vein thrombosis (dvt), cerebrovascular embolism, and other vascular occlusions.. .
Kp Medcure, Inc.

Vascular compression assist device and tactile hemostasis

A vascular compression assist device to achieve hemostasis comprises a generally c-shaped self-biasing member having a first free end spaced apart from a second free end forming a gap there between and the first end and second end bias in directions toward one another. An opening is provided through the member adjacent to the first end, and the opening is configured to receive one or more fingertips of a user.

Methods, systems, and devices for analyzing lung imaging data

Devices, methods, and systems are provided for analyzing lung imaging data. A server computing device receives imaging data of a lung over a network from a client computing device and analyzes the imaging data to identify lung, airways, and blood vessels, segment the lung into lobes, subtract airways, calculate volumes, calculate emphysema scores, identify fissure locations, calculate fissure completeness scores.
Pulmonx Corporation

Image processing apparatus and medical image diagnostic apparatus

An image processing apparatus according to an embodiment includes processing circuitry. The processing circuitry performs a fluid analysis using image data including a blood vessel to calculate an index value relating to blood flow in the blood vessel.
Toshiba Medical Systems Corporation

Portable measurement of cardiovascular health, system, and method thereof

The disclosure is related to a portable apparatus, and a system for measurement of cardiovascular health, and a method for the same. The portable apparatus is preferably a cuff-less blood pressure device that includes an electrode-based module and a piezoelectric sensor module.
Kentec Inc.

Systems and interfaces for blood sampling

The present invention generally relates to systems and methods for delivering and/or receiving a substance or substances such as blood from subjects. In one aspect, the present invention is directed to devices and methods for receiving or extracting blood from a subject, e.g., from the skin and/or from beneath the skin, using devices containing a substance transfer component (for example, one or more needles or microneedles) and a reduced pressure or vacuum chamber having an internal pressure less than atmospheric pressure prior to receiving blood.
Seventh Sense Biosystems, Inc.

Apparatus, systems, and methods for tissue oximetry and perfusion imaging

A compact perfusion scanner and method of characterizing tissue health status are disclosed that incorporate pressure sensing components in conjunction with the optical sensors to monitor the level of applied pressure on target tissue for precise skin/tissue blood perfusion measurements and oximetry. The systems and methods allow perfusion imaging and perfusion mapping (geometric and temporal), signal processing and pattern recognition, noise cancelling and data fusion of perfusion data, scanner position and pressure readings..
The Regents Of The University Of California

Measuring homeostatic risk

A method and system for determining homeostatic risk in a patient, in order to screen metabolic diseases and/or their complications and/or their treatment management, is provided. The method includes receiving, from one or more sensors coupled with the patient, galvanic skin response, bioimpedance, a photoplethysmogram (ptg), and blood pressure from the patient, executing a spectral analysis of the ptg, and calculating a homeostatic risk score based on the galvanic skin response, bioimpedance, blood pressure and ptg, and a display for displaying the homeostatic risk score..
Medical Screening Corporation

Blood pressure measurement device

The embodiment provides a blood pressure measurement device equipped with a pressing surface having plural pressure sensors arranged in one direction, an air bag for pressing the pressing surface against a living body part in a state that the one direction crosses a direction in which the radius artery t runs, an air bag drive unit, a rotational drive unit for driving the pressing surface rotationally about at least one of axes x and y, and a control unit which performs a rotation control on the basis of pressure pulse waves that were detected by the pressure sensors in a process that the pressing force was increased and calculates blood pressure values on the basis of pressure pulse waves that were detected by the pressure sensors after the rotation control in a process that the pressing force was decreased.. .
Omron Corporation

Blood pressure measurement device

A blood pressure measurement device is equipped with a pressing surface which is formed with an element array of plural pressure sensors arranged in one direction and an element array of plural pressure sensors arranged in the one direction, an air bag for pressing the pressing surface against a living body, a control unit for calculating blood pressure values in a radius artery on the basis of pressure pulse waves that are detected by the pressure sensors in a state that the pressing surface is pressed against the living body by the air bag, and a rotational drive unit for performing driving to rotate the pressing surface about each of axes that are perpendicular to a pressing direction of the air bag.. .
Omron Corporation

Blood pressure measurement device

A blood pressure measurement device is equipped with a pressing surface which is formed with pressure sensors, an air bag for pressing the pressing surface toward a radius artery that runs under a skin of a living body; an air bag drive unit for controlling the pressing force of the air bag, and a control unit for calculating blood pressure values in the radius artery on the basis of pressure pulse waves that were detected by all of the pressure sensors in a process that the pressing force was increased or decreased.. .
Omron Corporation

Blood pressure measurement device

The embodiment provides a blood pressure measurement device equipped with an air bag drive unit, a pressing surface formed with pressure sensors, and a control unit which calculates first blood pressure values on the basis of a first pressure pulse wave that was detected by the pressure sensors, generates calibration data using the first blood pressure values, and calculates second blood pressure values by calibrating, using the calibration data, a second pressure pulse wave that is detected by the pressure sensors in a state that the pressing force is set at an optimum pressing force. The control unit performs the processing of calculating second blood pressure values by calibrating the second pressure pulse wave if detection conditions of the second pressure pulse wave coincide with detection conditions of a pressure pulse wave used for generation of the calibration data..
Omron Corporation

Stabilization of whole blood samples

Methods for stabilizing blood samples, e.g., clinical blood samples, for storage or transportation before use. Exemplary applications include but are not limited to enrichment of leukocyte subtypes such as t-cells or neutrophils for cytokine and immuno-assays; isolation of progenitor cells from cord blood or peripheral blood for transplantation; isolation of fetal cells from the maternal blood for diagnosis; and sorting of circulating tumor cells for cancer detection and therapy..
The General Hospital Corporation

Antisecretory factor complex assay

The disclosed assay can be used for detecting levels of circulating 26s proteasome bound to complement factor 3 or 4 in blood plasma or other body fluids, such as for monitoring levels of inflammation and virus infection in the body of a mammalian, including complement system down regulation in the body of a mammalian as well as for verifying compliance of processed cereals (spc) and/or functional food with high levels of natural antisecretory protein (nasp).. .

Method and device for quality controlling a blood-based product

A method and device for quality controlling a blood-based product. In order to control the quality of a blood-based product which comprises an erythrocyte concentrate, a thrombocyte concentrate, a granulocyte concentrate, a leukocyte concentrate, whole blood and/or blood plasma, a raman spectrum is recorded.
Celltool Gmbh

Method for detecting sickle-cell disease and kit for implementing same

A method for detecting sickle-cell disease in an individual. A blood sample from an individual is brought into contact with an agent for inducing the sickling of red blood cells suitable for placing the red blood cells in a hypoxic condition.
Screencell

Method and automated whole blood sample analyses from microscopy images

A method and apparatus for identifying one or more target constituents (e.g., white blood cells) within a biological sample is provided. The method includes the steps of: a) adding at least one colorant to the sample; b) disposing the sample into a chamber defined by at least one transparent panel; c) creating at least one image of the sample quiescently residing within the chamber; d) identifying target constituents within the sample image; e) quantitatively analyzing at least some of the identified target constituents within the image relative to one or more predetermined quantitatively determinable features; and f) identifying at least one type of target constituent within the identified target constituents using the quantitatively determinable features..
Abbott Point Of Care, Inc.

Identifying and enumerating early granulated cells (egcs)

Methods and systems for automatically identifying and enumerating early granulated cells (egc) in blood samples are disclosed. In one embodiment a method for identifying egc in a blood sample includes analyzing white blood cells of the blood sample using a low angle light scatter (lals) parameter, separating the egcs from the other white blood cells using the lals parameter, and enumerating the separated egcs..
Beckman Coulter, Inc.

Pretreatment bacterial identification and antimicrobial susceptibility testing of positive blood culture samples

Provided is a blood culture treatment technology, including a novel treatment technology of performing pretreatment of a positive blood culture to effectively remove foreign substances such as cells, etc., thereby omitting a subculturing process on a solid medium and realizing rapid selection of antimicrobial agents for patients. The pretreatment method of a positive blood culture sample for bacterial identification and antimicrobial susceptibility testing includes preparing a first liquid culture by centrifuging a portion of a liquid medium including the positive blood culture sample, washing a precipitate thus centrifuged with a solution including sodium chloride, and then suspending the precipitate in the solution including sodium chloride, and preparing a second liquid culture by passing the first liquid culture thus prepared through a pretreatment filter including a mesh structure..
The Catholic University Of Korea Industry-academic Cooperation Foundation

Targeting micrornas for metabolic disorders

Provided herein are methods and compositions for the treatment of metabolic disorders. Also provided herein are methods and compositions for the reduction of blood glucose level, the reduction of gluceoneogenesis, the improvement of insulin resistance and the reduction of plasma cholesterol level.
Eth Zurich

Anti-glucagon antibodies and uses thereof

The present invention provides antibodies that bind to glucagon and methods of using the same. According to certain embodiments, the antibodies of the invention bind human gcg with high affinity.
Regeneron Pharmaceuticals, Inc.

Scaffold with drug coating for preventing and treating restenosis and preparation method thereof

Disclosed is a stent with a drug coating for preventing and treating restenosis, comprising, a stent and a drug coating covering the surface of the stent. The active ingredients in the drug coating are guaiane sesquiterpene compounds p1, p2 and p3.
Xiyuan Hospital Of China Academy Of Chinese Medical Sciences

Preparation for forming emboli and microcatheter

An object is to provide a preparation for forming emboli highly safe in a living body and capable of retaining and controlled-releasing an anticancer agent, occluding a blood vessel when injected into the blood vessel, unlikely to be washed out and having a controlled decomposition time (i.e., occludes a blood vessel for a while and quickly decomposes to prevent the necrosis of the entire tissues when the function is completed). The preparation for forming emboli according to the present invention comprises a solution comprising a phenolic hydroxyl group-modified polymer represented by the following formula (1): wherein p is a biocompatible polymer, a is a single bond or an —oco—c2-c4-alkenylene group, a —conh—c1-c4-alkylene group or an —hnco—c1-c4-alkylene group, and x is hydrogen or a c1-c3-alkoxy group, a solution comprising at least one selected from a peroxidase, a laccase, a tyrosinase, a catalase and an iron porphyrin complex and a solution comprising hydrogen peroxide..
Kagoshima University

A treating cancer based on metallofullerene monocrystalline nanoparticles that specifically disrupt tumor blood vessels

Metallofullerene monocrystalline nanoparticles are used as tumor vascular disrupting agents. The monocrystalline nanoparticles are water-soluble metallofullerene nanoparticles with negative charges on their surfaces.
Beijing Fullcan Bio-technology Co., Ltd.

Compositions, methods and uses for protecting white blood cells from suppression or death

Provided herein are compositions, methods and uses of humanin or a humanin analog, for example, in treating a subject with humanin or a humanin analog, in part, to protect white blood cells from suppression or cell death induced by an autoimmune, anti-tumor or anti-cancer therapeutic agent.. .
Los Angeles Biomedical Research Institute At Harbo-ucla Medical Center

Use of dehydroeburicoic acid from antrodia camphorata in the treatment or prevention of diabetes and hyperlipidemia

The present invention provides a method for treating type 1 diabetes, hyperlipidemia or hepatic lipid accumulation by using dehydroeburicoic acid, as well as a method for decreasing levels of blood glucose, plasma total cholesterol, and triglyceride, and increasing insulin levels; and a method for decreasing hepatic balloon degeneration; and increasing expression levels of membrane glut4 and phospho-akt in myotubes; and enhancing expression levels of membrane glucose transporter 4 (glut4) in skeletal muscle, and phospho-ampk in both skeletal muscle and liver tissue using dehydroeburicoic acid.. .

Compositions of aluminum fluoride and methods of use thereof for the treatment and prevention of actinic keratosis and sun-induced damages

The present invention is directed to methods and compositions for the treatment or prevention of actinic keratosis and/ or for countering the effects of skin aging and/ or damage to blood vessels and fine wrinkling. The present invention provides for a composition comprising aluminum fluoride or chemical compounds which releases aluminum fluoride to be used to treat or reduce the negative effects of actinic keratosis or sun-induced skin aging and associated conditions, for example, damaged blood vessels and fine wrinkling..

Methods, compositions, and formulations for preventing or reducing adverse effects in a patient

The present invention provides methods, compositions, formulations, and kits related to acadesine, or a prodrug, analog, or salt thereof, and/or a blood clotting inhibitor for preventing or reducing adverse side effects in a patient. The type of patient that may benefit includes a patient with decreased left ventricular function, a patient with a prior myocardial infarction, a patient undergoing non-vascular surgery, or a fetus during labor and delivery..
Pericor Therapeutics, Inc.

Aspirin formulation for increased efficacy

Provided are methods for enhancing the efficacy of aspirin. Also provided are methods for reducing pain or preventing or treating heart attack, stroke or blood clot in a subject in need thereof.
Vitalis Llc

Cervical distraction method

A device and method for a minimally invasive surgical implantation to reduce radicular symptoms by inserting an expandable cervical distraction implant in the facet joint and distracting the adjacent cervical vertebrae to increase the foraminal dimension. The implant, when positioned in the cervical facet joint, expands to via delivery of an inflation medium to increase the space between the vertebrae, thereby increasing the foraminal area or dimension, and reducing pressure on the nerves and blood vessels of the cervical spine..
Providence Medical Technology, Inc.

Devices for reducing left atrial pressure having biodegradable constriction, and methods of making and using same

A device for regulating blood pressure between a patient's left atrium and right atrium comprises an hourglass-shaped stent comprising a neck region and first and second flared end regions, the neck region disposed between the first and second end regions and configured to engage the fossa ovalis of the patient's atrial septum; and a one-way tissue valve coupled to the first flared end region and configured to shunt blood from the left atrium to the right atrium when blood pressure in the left atrium exceeds blood pressure in the right atrium. The inventive device may include a biodegradable material that biodegrades to offset flow changes caused by tissue ingrowth.
V-wave Ltd.

Controlled tissue ablation techniques

Apparatus and methods are described, including a method for use with tissue of a renal nerve (770) passing longitudinally within a wall of a renal artery (8) of a subject. Using one or more stimulating electrodes (850a, 850b) disposed within the renal artery, the tissue is stimulated by passing a stimulating current through the wall of the renal artery.
Pythagoras Medical Ltd.

Clot removal device

A system may comprise a clot engagement element having a collapsed delivery configuration and an expanded configuration for engaging with a clot and for dislodging the clot from a first vessel segment. An elongate member may be configured to apply a pull force to the clot engaging element to dislodge the clot from the first vessel segment.
Neuravi Limited

Partially covered braided funnel aspiration catheter

The disclosure generally relates to methods and devices for removing a blockage from an anatomical passageway, for example thrombus or clot from a blood vessel. Devices and methods are provided for removing a blockage from an anatomical passageway.
Cook Medical Technologies Llc

Transcatheter device and minimally invasive constricting and adjusting blood flow through a blood vessel

A pulmonary artery flow restrictor system includes a funnel shaped membrane with a proximal base and a restrictive distal opening which is stretchable to larger sizes. A self-expanding frame is attached to the proximal base of the membrane for securing the membrane within the pulmonary artery..
Vivonics, Inc.

Method and displaying ultrasound image

Provided are methods and apparatuses for displaying ultrasound images. Methods and apparatuses for displaying ultrasound images according to one or more embodiments may determine a stenosis cross-section from ultrasound data with respect to an object including a blood vessel and display at least two cross-sections related to stenosis of the blood vessel and a stenosis index value representing a degree of stenosis of the blood vessel, thereby improving diagnostic usability for a user..
Samsung Medison Co., Ltd.

Modular sensing guidewire

A sensing guidewire device used to measure physiological parameters within a living body. In one embodiment, the device is used to measure the fractional flow reserve (ffr) across a stenotic lesion in a patient's vasculature.

Multifunctional wireless intelligent monitor

The disclosed wireless digital monitor, if is used in a residence for one patient, comprises a detector, a pager, a video camera vc, one or more door detectors dd and a computer pc. Said detector comprises a three axis accelerometer acc, a sensor for body temperature tb, a sensor for surrounding temperature te, a temperature sensor td for urine detection in diaper, microphone with amplifier mic, an oximeter with pulse detection and blood pressure meter, two microcontrollers working with software control data from all sensors above and transmit it to a transmitter or a transceiver.

Systems and methods for monitoring and evaluating neuromodulation therapy

Systems and methods for informing and evaluating neuromodulation therapy are disclosed herein. A system configured in accordance with embodiments of the present technology can include, for example, a guidewire having a proximal portion, a distal portion configured to be positioned at a target site in a blood vessel of a human patient, and a sensing element positioned along the distal portion.
Medtronic Ardian Luxembourg S.a.r.l.

Blood sampler

A blood sampler includes a hollow transparent barrel including a reduced collection portion located at a front end thereof and terminating in a reduced coupling portion, an outlet defined in the coupling portion and a plurality of ribs spaced around and raised from an inside wall near an opposing rear end thereof, a piston axially movably fitted into the hollow transparent barrel and having a screw hole and peripheral ribs, a cap detachably capped onto the collection portion to seal the outlet, and a plunger having a screw rod located at a front end thereof and threaded into the screw hole of the piston for allowing movement the piston with the plunger. The hollow transparent barrel enables collecting blood sample from a patient, separating the collected blood sample into platelet-rich plasma, platelet-rich plasma and serum in a centrifuge and injecting the collected platelet-rich plasma into a patient body..
Jieryang Biotech, Inc.

Biological information acquisition device and biological information acquisition method

A biological information acquisition device selects a light emitting unit located above a blood vessel as a measurement light emitting unit, and selects a light receiving unit spaced apart from the measurement light emitting unit by a predetermined distance and located above the blood vessel as a measurement light receiving unit and causes the measurement light receiving unit to acquire a first light receiving result. The device selects a light emitting unit which is not located above the blood vessel as a reference light emitting unit, and selects a light receiving unit spaced apart from the reference light emitting unit by the predetermined distance and not located above the blood vessel as a reference light receiving unit and causes the reference light receiving unit to acquire a second light receiving result..
Seiko Epson Corporation

Low volume blood pressure meter and cuff thereof

A low volume or narrower blood pressure cuff compared to commercial counterparts with similar medical approval accuracy is introduced. The present invention comprises an occlusion component configured to occlude the artery, and a pulse wave detection component to detect blood pressure oscillations.
Nec Corporation

Non-invasive and non-occlusive blood pressure monitoring devices and methods

A blood pressure monitoring device includes a body portion having a size and structure to extend around an appendage of a user during use, a fluid bladder at least one of attached to or integral with the body portion and arranged to be able to apply pressure to an adjacent artery or vein of the user during use, a pressure actuator fluidly connected to the fluid bladder, a controller configured to provide control signals to the pressure actuator to fill the fluid bladder to selected pressures, a signal processor configured to communicate with the controller to receive signals indicating the selected pressures to which the fluid bladder is filled, and a pressure sensor arranged in operative contact with the fluid bladder to measure blood pressure waveforms plus bladder fluid pressure to provide a pressure waveform signal containing information regarding a relationship between vessel distention and transmural pressure. The pressure sensor is further configured to communicate with the signal processor to provide the pressure waveform signal to the signal processor.
Angilytics Inc.

Hemadynamometer and mobile terminal including the same

A hemadynamometer and a mobile terminal including the same are disclosed. The hemadynamometer includes first and second pulse wave sensors disposed apart from each other, each converting a pulse wave signal corresponding to a blood pressure into an electric signal, a pressurization unit for applying a pressure to a wrist to change a diameter of a blood vessel, and a controller to measure the blood pressure based on first and second pulse wave signals detected respectively by the first and second pulse wave sensors before a predetermined pressure is applied to the wrist by the pressurization unit, and third and fourth pulse wave signals detected respectively by the first and second pulse wave sensors after the predetermined pressure is applied to the wrist by the pressurization unit.
Lg Electronics Inc.

Automated assessment of peripheral vascular condition

An automated assessment of a patient's peripheral vascular condition includes using a pulse oximeter to generate at least a perfusion index relative to a limb or digit of the patient. Pressure is applied to the limb or digit, and while increasing or decreasing the pressure, a change in the perfusion index is determined.
D. E. Hokanson, Inc.

Wireless pairing of personal health device with a computing device

Systems and methods for the wireless pairing of a personal health device (phd) (e.g., blood glucose monitor) with a computing device (e.g., smartphone) are disclosed herein. In an embodiment, the phd communicates a private key to the computing device via a first communication medium (e.g., light signal, audio signal, pattern).
Trividia Health, Inc.

Titration of basal insulin with two modes

Titration of basal insulin with two modes based on fasting blood glucose. Although it seems that the titration of basal insulin and insulin glargine is simple for the patient (user) there is a risk for over-titration observed due to an occasional or short-term high blood glucose measurement value.
Sanofi-aventis Deutschland Gmbh

Automatic analysis apparatus

Provided is an automatic analysis apparatus for inspecting blood coagulation, which is capable of miniaturizing device configuration and reducing device costs. The automatic analysis apparatus includes: a reaction container in which a specimen and a reagent are mixed with each other and the mixed solution is reacted; a sample dispensing mechanism which dispenses the specimen into the reaction container; a blood coagulation time measuring unit in which the reaction container is mounted to measure a coagulation time of the mixed solution within the reaction container; a reaction container accommodating unit which accommodates a plurality of reaction containers provided to the blood coagulation measuring unit; a reaction container transfer mechanism which grasps the reaction container and transfers the reaction container to the blood coagulation measuring unit; and a control unit which controls the reaction container transfer mechanism, wherein the control unit controls the transferring and mounting of the reaction container, into which the specimen is dispensed, to the reaction container accommodating unit by means of the reaction container transfer mechanism..
Hitachi High-technologies Corporation

Test strips for determining coagulation factor activities

Test strips for determining the activity of a coagulation factor in a blood sample are provided. The strip comprises a support, a sample inlet port for deposition of a blood sample, and a reaction area comprising a blood coagulation reagent.
Cgt Enterprises, Llc

Dicarboxylic acids and correlated compounds as a measure of red blood cell quality

Compositions and methods for determining post-transfusion survival or toxicity of red blood cells and the suitability of red blood cell units for transfusion by measuring the levels of one or more compounds in a red blood cell sample are provided.. .
Bloodworks

Cell counting

Systems and methods for classifying blood cells in a blood sample are disclosed. A series of frames of the blood sample as it flows through a field of view of an image capture device are captured and analysed.
Biosurfit S.a.

High-purity galactooligosaccharide compositions, preparations, and applications thereof

Provided is a method of preparing a high-purity galactooligosaccharide composition by fermentation of a low-purity galactooligosaccharide mixture with a yeast strain, kluyveromyces lactis atcc 8585. The high-purity galactooligosaccharide composition includes at least 99% of galactooligosaccharides selected from the group consisting of galactotriose, galactotetrose, galactooligosaccharides with five or more sugar units, and combinations thereof and lower than 1% of monosaccharides and disaccharides.
King-prebiotics Biotechnology (tw) Co., Ltd.

Recombinant adeno-associated vectors for targeted treatment

Novel adeno-associated virus (aav) vectors in nucleotide and amino acid forms and uses thereof are provided. The isolates show specific tropism for certain target tissues, such as blood stem cells, liver, heart and joint tissue, and may be used to transduce stem cells for introduction of genes of interest into the target tissues.
City Of Hope

Recombinant adeno-associated vectors for targeted treatment

Novel adeno-associated virus (aav) vectors in nucleotide and amino acid forms and uses thereof are provided. The isolates show specific tropism for certain target tissues, such as blood stem cells, liver, heart and joint tissue, and may be used to transduce stem cells for introduction of genes of interest into the target tissues.
City Of Hope

Recombinant adeno-associated vectors for targeted treatment

Novel adeno-associated virus (aav) vectors in nucleotide and amino acid forms and uses thereof are provided. The isolates show specific tropism for certain target tissues, such as blood stem cells, liver, heart and joint tissue, and may be used to transduce stem cells for introduction of genes of interest into the target tissues.
City Of Hope

Recombinant adeno-associated vectors for targeted treatment

Novel adeno-associated virus (aav) vectors in nucleotide and amino acid forms and uses thereof are provided. The isolates show specific tropism for certain target tissues, such as blood stem cells, liver, heart and joint tissue, and may be used to transduce stem cells for introduction of genes of interest into the target tissues.
City Of Hope

Method and automated processing of pooled samples

The present invention relates to a novel method for automated processing of pooled samples, particularly blood samples. Furthermore, the present invention pertains to an apparatus for carrying out the method and the corresponding uses.
Gfe Blut Mbh

Antibodies that recognize red blood cell antigens

Compositions and methods of using antibodies that are able to recognize single amino acid polymorphisms in a protein are provided. Compositions are disclosed which may be used for blood typing or to block hemolytic transfusion reactions and/or hemolytic disease of the fetus and newborn..
Bloodworks

Intravenous catheter and insertion device with reduced blood spatter

A catheter insertion device and method for insertion. The catheter insertion device can include a housing, a needle attached to a needle carrier, a catheter including a catheter shaft attached to a catheter hub, and a guidewire.
Vascular Pathways, Inc.

Blood pressure reduction with dietary supplements

blood pressure reduction with dietary supplements abstract a daily dose of 6,000 mg of taurine, 1,000 mg of vitamin c, 150 mg of grape seed extract, 100 mg of vitamin b6, 2 mg of biotin, 2,000 iu of vitamin d3, and 87 mg of magnesium is shown to reduce blood pressure in hypertensive individuals by. .

Composition for treating obesity and diabetes and for increasing muscle mass and improving capacity for exercise, comprising extracts of piper retrofractum vahl. fruits as active ingredients

The present invention relates to a food composition, and to a pharmaceutical composition, which exhibit anti-obesity effects by means of a thermogenesis produced by an activity of a ucp of fat cells, which exhibit anti-diabetes effects by means of an improved insulin resistance, increase muscle mass, and improve capacity for exercise. More particularly, the present invention relates to a novel use of a composition containing extracts of piper retrofractum, and to the food composition or pharmaceutical composition which exhibit anti-obesity effects by means of decreased body weight and body fat, exhibit anti-diabetes effects by means of ameliorated insulin resistance through the reduction of blood glucose and blood insulin, increase muscle mass by increasing an energy source being supplied to the muscles, and improve the capacity for exercise including increased endurance..
Industry-academic Cooperation Foundation, Yonsei University

Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of diabetes

The present invention concerns the use of compounds for preventing and/or treating diabetes, for modulating glucose, insulin, and/or triglyceride levels; for reducing blood glucose level; for maintaining or increasing insulin level; for increasing insulin secretion; increasing insulin sensitivity; or decreasing insulin resistance in a subject. These novel uses have been found for compounds represented by formula i and pharmaceutically acceptable salts.
Prometic Pharma Smt Limited

Vascular prosthesis system

The invention relates to a vascular prosthesis system for inserting into and for supporting a blood vessel of a patient. The vascular prosthesis system comprises (i) a stent graft element comprising a prosthesis material, and (ii) a stent element free of prosthesis material.
Jotec Gmbh

Intravascular catheter having an expandable incising portion

An intravascular device is provided having a catheter tube with an expandable portion located on an end thereof. The expandable portion includes a plurality of struts capable of being moved between an open and a closed position.

Intravascular catheter having an expandable incising portion and grating tool

An intravascular device is provided having an expandable portion including a plurality of struts capable of being moved between an open and a closed position. A grating tool is provided on at least one of the struts.

Surgical ligation clip

A polymeric, surgical clip is provided for clamping a blood vessel between two legs. A hook section of the clip comprises, in some embodiments, a sharpened forward edge and/or a sharpened rearward edge for penetrating connective tissue adjacent a vessel before closing the surgical about a blood vessel.

System and apparatus comprising a multisensor guidewire for use in interventional cardiology

A system (1) and apparatus comprising a multisensor guidewire (100/200/300) for use in interventional cardiology, e.g., transcatheter valve therapies (tvt), comprises a plurality of optical sensors (10/20) for direct measurement of cardiovascular parameters, e.g. Transvalvular blood pressure gradients and flow.
Three Rivers Cardiovascluar Systems, Inc.

Hand-held optical scanner for real-time imaging of body composition and metabolism

A low cost portable high speed quantitative system for diffuse optical spectroscopic imaging of human tissue. The hybrid system (cwfd) can measure absolute optical properties from 660 nm to 980 nm and recover all tissue chromophore concentrations.
The Regents Of The University Of California

Device, non-invasively measuring blood glucose

Device and method for non-invasively measuring the level of glucose in blood. The device comprises a light shielded chamber, a light emitter operative to emit light in the green-turquoise (gt) wavelength range into the light shielded chamber, a detector operative to detect gt light in the gt wavelength range in the light shielded chamber, a tissue receiving area for removably receiving at least a part of a human tissue such to be housed within the light shielded chamber so that the emitted light is incident onto the human tissue, and a monitoring engine operative to determine a level of glucose in blood based on the amount of emitted and detected gt light..
Biolab Technologies Ltd.

Calibration of pulse-transit-time to blood pressure model using multiple physiological sensors and various methods for blood pressure variation

Disclosed are devices and methods for estimating blood pressure, which implement a pulse-transit-time-based blood pressure model that can be calibrated. Some implementations provide reliable and user friendly means for calibrating the blood pressure model using blood pressure perturbation methods and multiple sensors..
Fitbit, Inc.

Biological information reading device

The present invention continuously acquires information on the pulse wave and blood pressure of a measurement subject. The present invention is a biological information reading device that is used stuck to a living body and that is provided with: a biological information acquiring unit that is stuck to the living body and that acquires biological measurement information; and a computing unit that, on the basis of the biological measurement information acquired by the biological information acquiring unit, performs computations that generate biological information.
Shinano Kenshi Co., Ltd.

Remote vital sign detection device and system for non-implantable medical devices and related methods

A remote vital sign detection device has a sensor, an integrated circuit, and antenna. The integrated circuit is in communication with the sensor and the antenna.
Poiesis Medical, Llc

Robotic control of an endoscope from blood vessel tree images

A robot guiding system employs a robot unit (10) and a control unit (20). The robot unit (10) includes an endoscope (12) for generating an intra-operative endoscopic image (14) of a blood vessel tree within an anatomical region, and a robot (11) for moving the endoscope (12) within the anatomical region.
Koninklijke Philips N.v.

Mobile diagnostics laboratory, communications systems, and related methods

A mobile laboratory for screening patients using blood testing is provided. The mobile laboratory includes: a cell analyzer platform for testing of blood samples; a computer for receiving and analyzing data from the cell analyzer platform related to the tested blood samples; and a communication device, in communication with the computer, for transmitting data related to the tested blood samples from the computer to a third party..
Flowmetric Diagnostics Inc.

Noninvasive discrimination method and discrimination system of chromosomal heteroploidy of fetus

The present invention provides a noninvasive discrimination method of chromosomal heteroploidy of a fetus, the method including a step of analyzing dna of a candidate cell of a nucleated red blood cell isolated from maternal blood, in which the fetuses are fetuses classified into any one case selected from monotocous, monochorionic monoamniotic twin fetuses, monochorionic diamniotic twin fetuses, and dichorionic diamniotic twin fetuses based on results of ultrasonic inspections and the number of candidate cells of nucleated red blood cells to be used for analyzing the dna is optimized based on the classification, and a noninvasive discrimination system of chromosomal heteroploidy of a fetus.. .
Fujifilm Corporation

Method of analyzing diluted biological sample component

There is provided a method of analyzing a biological sample component that allows easy and accurate quantification and counting of any of a plasma component and a blood cell component in a trace and unknown amount of a whole blood sample collected from a finger, for example. The method of the present invention is a method of analyzing a biological sample component in a trace amount of blood, comprising analyzing a diluent buffer into which the blood has been mixed and an internal standard substance and/or an external standard substance contained in the diluent buffer, calculating a dilution ratio, and analyzing a biological component in a plasma or serum component in the blood..
Leisure, Inc.

Biochemical markers of red blood cell storage and toxicity

Compositions and methods for determining post-transfusion survival or toxicity of red blood cells and the suitability of red blood cell units for transfusion by measuring the levels of one or more markers in a red blood cell sample are provided.. .
Bloodworks

Method for detecting cardiac failure patient

A method for detecting a cardiac failure patient is provided. The method comprises (1) measuring a value of ckap4 in a blood sample collected from a subject; (2) comparing the measured value of ckap4 with a predetermined standard value; and (3) determining the subject as being a cardiac failure patient when the measured value of ckap4 in the blood sample of the subject is lower than the predetermined standard value..

Biochemical markers for use in determining risk of diabetes

A method for predicting risk of gestational diabetes mellitus (gdm) in a pregnant individual includes measuring one or more biochemical markers in a blood sample obtained from the pregnant individual to determine one or more biomarker levels, where the one or more measured biochemical markers includes at least one of amylin, 17β-estradiol, and lipocalin-2, identifying, for each of the one or more measured biochemical markers, a difference between the measured biomarker level and a corresponding predetermined control level, and, responsive to the identifying, determining a prediction corresponding to a relative risk of the pregnant individual having or developing gdm.. .
Wallac Oy

Method and device for the raman spectroscopic, in ovo sex determination of fertilised and incubated birds' eggs

The invention relates to a method for the raman spectroscopic, in ovo sex determination of fertilised and hatched birds' eggs (1), wherein the embryo, including the extra-embryonic structures, can move in the egg, and is not yet attached to the shell at the time of measuring. In addition, the following steps are carried out: monitoring the time course of the hatched egg until forming at least one recognisable blood vessel (21); creating a hole (2) in the shell in the region near to the attached bloody vessel, using a hole-generating unit; finding the blood vessel forming in the egg, using a vision system (19, 13) and a coaxial or lateral illumination with light (10a) in the visible wavelength range; positioning at least one blood vessel in the laser focus of a laser source (3), either by moving the egg or moving a lens (6) of a device (5) for introducing the laser light (3a), and detecting the raman scattered radiation (7); registering the raman scattered radiation of the irradiated blood vessel using the device for introducing the laser light, and for detecting the raman scattered radiation, wherein, during the measuring process, a movement of the blood vessel out of the focus can be avoided by tracking using the vision system; evaluating the raman scattered radiation in an evaluation unit; determining and displaying the sex of the embryo in the bird's egg..
Universitaet Leipzig

Process and molecular biomarker

A process and molecular biomarker for platelets stored in blood banks provides for efficient verification of which platelet concentrate bags are in good condition for transfusion by measuring, by real-time polymerase chain reaction, expression levels of hsa-mir-127 and hsa-mir-320a micrornas as the first process and biomarker predictor of platelet's cell aging during storage and the consequent presence of storage lesions as a quality test of these bags.. .
Centro De Hemoterapia E Hematologia Do Para - Hemopa

Isolated gdf trap polypeptide

In certain aspects, the present invention provides compositions and methods for increasing red blood cell and/or hemoglobin levels in vertebrates, including rodents and primates, and particularly in humans.. .
Acceleron Pharma Inc.

Temporary occlusion balloon devices and methods for preventing blood flow through a vascular perforation

A device for occluding a perforation in a blood vessel includes an expandable member. The expandable member includes a central expandable balloon disposed between a proximal and a distal balloon, wherein the proximal and distal balloons each contain first and second compositions, respectively.
The Spectranetics Corporation

Adjusting insulin delivery rates

A method includes receiving up-to-date blood glucose data for a pwd, determining basal insulin dosages for the pwd based on a baseline basal rate, delivering the basal insulin dosages to the pwd, modifying a target blood glucose level based on variability of blood glucose data for the pwd, receiving a temporary override indicating a user preference to reduce the likelihood that the pwd has a hypoglycemic event or a user preference to reduce the likelihood that the pwd has a hyperglycemic event, determining a temporary target blood glucose level based on the input—greater than the modified blood glucose level if the preference is to reduce the likelihood of a hypoglycemic event—lower than the modified target blood glucose level if the preference is to reduce the likelihood that of a hyperglycemic event. The method includes delivering basal insulin for the temporary period of time based on the temporary target..
Bigfoot Biomedical, Inc.

Adjusting insulin delivery rates

A method may include delivering insulin, using an insulin pump and a controller, over a first diurnal time period based on a baseline basal insulin rate stored in memory. The controller may receive blood glucose data to control delivery of insulin via the insulin pump in amounts variable from the baseline basal insulin rate to control blood glucose levels for a person with diabetes (pwd).
Bigfoot Biomedical, Inc.

Adjusting insulin delivery rates

A method may include generating a first plurality of insulin delivery profiles that include a first series of insulin delivery actions spanning a first time interval, projecting a first plurality of future blood glucose values for each profile of the first plurality of profiles using up-to-date blood glucose levels, selecting one of the first plurality of profiles based upon comparing future blood glucose values for each profile and target blood glucose levels, delivering insulin for a second time interval that corresponds to a first action of the first profile, generating a second plurality of insulin delivery profiles for a third time interval, projecting a second plurality of future blood glucose values for each profile of the second plurality of profiles for the third time interval, and delivering a second dose of insulin for a fourth time interval shorter than the third time interval.. .
Bigfoot Biomedical, Inc.

Composition, cell structure, pancreatic islet transplantation kit, pancreatic islet cell transplantation treatment agent and hypoglycemic agent, composition containing pancreatic islet, kit containing pancreatic islet, and pancreatic islet transplantation treatment agent and hypoglycemic agent

An object of the present invention is to provide a composition containing a pancreatic islet, a cell structure containing a pancreatic islet or a pancreatic islet cell, a pancreatic islet transplantation kit, a pancreatic islet transplantation treatment agent, and a hypoglycemic agent which improve at least one of glucose sensitivity or blood sugar level-reducing performance after transplantation, and to provide a composition containing a pancreatic islet, a kit containing a pancreatic islet, a pancreatic islet cell transplantation treatment agent, and a hypoglycemic agent which can improve glucose sensitivity. According to the present invention, a composition including a: a cell structure which contains a biocompatible macromolecular block and at least one kind of cell and in which a plurality of the above-described macromolecular blocks are arranged in gaps between a plurality of the above-described cells; and b: a pancreatic islet, and a composition containing a pancreatic islet; and a spheroid formed of at least one type of stem cell are provided..
Fujifilm Corporation

Bipolar trans cartenoid salts and their uses

The invention relates to trans carotenoid salt compounds, methods for making them, methods for solubilizing them and uses thereof. These compounds are useful in improving diffusivity of oxygen between red blood cells and body tissues in mammals including humans..
Diffusion Pharmaceuticals Llc

Methods and compositions for increasing the anaerobic working capacity in tissues

Provided are compositions comprising beta-alanylhistidine peptides and/or beta-alanines, and methods for administering these peptides and amino acids. In one aspect, the compositions and methods cause an increase in the blood plasma concentrations of beta-alanine and/or creatine..
Natural Alternatives International, Inc.

Conical vena cava filter with jugular or femoral retrieval

A removable intravascular filter having a filtering configuration for capturing thrombi in a blood vessel and a retrieval configuration for removal from the blood vessel. The filter may be implanted in a patient's vena cava and may be removed from the vena cava through the patient's jugular or femoral vein.
Cook Medical Technologies Llc

Devices and methods for forming a fistula

Described here are devices, systems, and methods for forming a fistula between two blood vessels. The systems may comprise a first catheter including a housing and an electrode having a proximal end and a distal end.
Tva Medical, Inc.

Catheter guidance and procedure planning

A method includes, using a computer processor: (1) generating a map of vasculature of a subject, by: (a) displaying (i) a schematic representation of the vasculature including a blood vessel, and (ii) on the schematic representation, a first plurality of branch-site options; (b) receiving a user-selected first branch site, and responsively displaying (i) a schematic representation of a first branch of the vasculature that branches from the schematic representation of the blood vessel at the user-selected first branch site, and (ii) a second plurality of branch-site options; and (c) receiving a user-selected second branch site; (2) in response to receiving the user-selected second branch site, displaying the map; (3) detecting a physiological parameter of the subject; and (4) in response to the detected physiological parameter, determining a value for the parameter, and storing, in association with a location on the map, data representative of the value.. .
Rainbow Medical Ltd.

Vascular closure devices and methods providing hemostatic enhancement

Vascular closure devices and methods for closing a blood vessel puncture site disposed at a distal end of a tissue tract are described. A combination of the body's own natural mechanism with chemical and/or biological agents is relied upon to accelerate the hemostatic process.
Cardiva Medical, Inc.

Cannula assembly

This disclosure provides a cannula assembly with a flexible cannula that can be used for blood withdrawal or delivery of fluid that utilizes a main cannula that fixed with its end in a blood vessel that uses the cannula as a passageway into the blood vessel.. .

Apparatus for detecting cells in circulating bloodstream

A device for the real-time in vivo detection of a number of conditions within the patient, including ctcs, circulating nucleic acids, other circulating elements, blood pressure, heart rate data, pulse oxygen concentration, serum electrolyte concentrations, blood glucose, and ph, the device having an implanted subcutaneous access port in the chest region and a catheter having a terminus in the superior vena cava, the device having microelectronic circuitry with a rechargeable energy source encased in a titanium shell, an nir laser sealed in the titanium-enclosed circuitry platform, and nir-specific optical fibers (nir-fo) for transmitting the nir photons to the end of the catheter tube in the superior vena cava. Scattered nir photons are collected through the end of a second nir-fo bundle and transmitted back to the detector and microprocessor on the portal platform..
Lifebridge Health, Inc.

Wireless monitoring system

At least one sensor in a wearable device worn by a user may be configured to detect at least one of an electrocardiogram (ecg) signal and arterial pulse (or photoplethysmogram (ppg)) signal. At least one processing circuit may process the ecg signal, the pulse/ppg signal, or both to determine at least one of a pulse transit time (ptt) and pulse arrival time (pat).
Zansors Llc

Stabilization of metabolically-active cells in a blood sample at ambient temperatures

The present invention relates to the stabilization of one or more metabolically-active cell in a blood sample at ambient temperatures. In particular, formulations, compositions, articles of manufacture, kits and methods for substantially stable storage of one or more metabolically-active cell in a blood sample at ambient temperatures are provided..
Biomatrica, Inc.

User interface for diabetes management system

A diabetes management system including a pump for dispensing a medicant and a control device for controlling the pump includes a user interface for controlling functions of the pump and providing information related to operation of the pump and other information. The user interface can display blood glucose information and insulin dosing data such that a user can appropriately act on the information and/or gain confidence that the diabetes management system is operating appropriately to manage the disease.
Bigfoot Biomedical, Inc.

Blood biomarker for early blood brain barrier disruption in ischemic stroke

Methods and apparatus for determining blood brain barrier (bbb)damage and treating patients who may have suffered from bbb damage due to an ischemic event are provided. The methods and apparatus involve detecting the presence of cleaved occludin fragments in a sample of blood.
Stc.unm

Biomarkers of oxidative stress

The present invention relates to a method for detecting cardiovascular oxidative stress in an individual, comprising detecting in a blood sample from the individual modification of a cysteine at position 45 of the β1-subunit of the human erythrocyte atp-dependent na+k+ pump protein or of an equivalent cysteine in a homologue or variant thereof. The invention further relates to a kit for detecting cardiovascular oxidative stress in an individual, the kit comprising at least one agent for detecting the presence of a modification in a cysteine at position 45 of the β1-subunit of the human erythrocyte atp-dependent na+k+ pump protein or of an equivalent cysteine in a homologue or variant thereof, wherein said modification is a result of oxidation..
Northern Sydney Local Health District

Methods for diagnosing and treating eosinophilic esophagitis

Disclosed are methods of diagnosing and treating a subject with active or inactive eosinophilic esophagitis (eoe). The methods may include the steps of detecting whether a level of eosinophil lineage-committed progenitor (eop) is elevated in a blood sample obtained from a subject, diagnosing the subject with active eoe when an eop level in the sample is elevated above a pre-determined cut-off value and diagnosing the subject with inactive eoe when the eop level in the sample is below a pre-determined cut-off value; and treating the subject diagnosed with active eoe.
Children's Hospital Medical Center

Process for isolating a purified cell population isolated from whole blood

A purified solution of human plasma, mncs and platelets isolated from whole blood, bone marrow, or stromal vascular fraction cells separated from adipose tissue wherein said purified solution comprises at least 90% by number of the mncs in said whole blood, bone marrow, or stromal vascular fraction cells separated from adipose tissue, said purified solution comprises at most 10% by number of the red blood cells and granulocytes in said whole blood, bone marrow, or stromal vascular fraction cells separated from adipose tissue, and said purified solution is isolated and separated from said whole blood, bone marrow, or stromal vascular fraction cells separated from adipose tissue during a single centrifugation run.. .
Syngen Inc.

Method for prediction of fetal monogenic genetic variations using maternal serum dna

The present invention provides a method for non-invasively detecting, expecting, or diagnosing fetal single nucleotide polymorphisms and the resultant monogenic disorders, through maternal cell-free dna sequencing. The diagnosis method according to the present invention does not harm mothers or fetuses and is convenient, in that analysis is possible using maternal blood samples; and can be favorably used for a prenatal diagnosis method capable of determining at an early stage whether single nucleotide polymorphisms causing monogenic disorders occur or not.
Sk Telecom Co., Ltd.

Stabilization of non-denatured polypeptides, nucleic acids, and exosomes in a blood sample at ambient temperatures

Provided herein are formulations for the stabilization of one or more polypeptide or nucleic acid molecule in a native, non-denatured state at ambient temperatures. Also provided are compositions, articles of manufacture, kits and methods for substantially stable storage of one or more polypeptide or nucleic acid molecule in a native, non-denatured, and/or functionally active conformation substantially free on intracellular polypeptides and nucleic acids at ambient temperatures are provided.
Biomatrica, Inc.

Microfluidic device for cell separation and uses thereof

The invention features methods for separating cells from a sample (e.g., separating fetal red blood cells from maternal blood). The method begins with the introduction of a sample including cells into one or more microfluidic channels.
The General Hospital Corporation

Devices and methods for overlaying blood or cellular suspensions

A device is described that overlays a first fluid, such as blood or a cellular suspension onto a base material, such as a density gradient. In some embodiments, the fluid layering device includes a cylindrical reservoir, a fluid barrier, a coupling extension, a plunger, and an exhaust vent.

Systems and methods for controlling reperfusion in a vessel

A system for controlling reperfusion in a blood vessel of a patient including a flexible elongated member configured and dimensioned for insertion in the vessel of the patient, the elongated member having a proximal portion and a distal portion, the elongated member configured for insertion so the distal portion extends distal of a clot in the blood vessel. A sensor is positioned at the distal portion of the elongated member for positioning distal of the blood clot, the sensor measuring a parameter of blood downstream of the clot.
Makaha Medical, Llc.

Medical device

The invention provides a medical device including a resin tube having excellent branch selectivity while excellent pushability in a curved body cavity or an extremely narrow body cavity such as a blood vessel terminal region is maintained. Provided is a medical device having a medical device body to be inserted into a body cavity.
Sumitomo Bakelite Co., Ltd.

Oxyntomodulin analogs and methods of making and using same

Provided are oxyntomodulin analogs. The peptide analogs have at least two cysteines.
California Institute For Biomedical Research

Devices and methods for control of blood pressure

Apparatus and methods are described including an implantable device having first and second longitudinal ends, the device having a length of less than 80 mm when the device is unconstrained. The device includes struts arranged such that, when the device is unconstrained, along a continuous portion of the device having a length that is at least 5 mm, a maximum inter-strut distance defined by any set of two adjacent struts is more than 1.5 times as great as a maximum inter-strut distance defined by any set of two adjacent struts within longitudinal portions of the device within 3 mm of the longitudinal ends of the device.
Vascular Dynamics, Inc.

Method and device for determining the central systolic blood pressure

Determining the central systolic blood pressure as the maximum of the all-pass-filtered and average-filtered blood pressure curves, as well as a device for performing this method.. .

Intermittent measuring of the partial pressure of an analyte in the skin tissue

It is commonly known within the art of cutaneous/transcutaneous blood gas monitoring to warm up the skin of the patient to allow carbon dioxide and oxygen to diffuse easily through the skin. This is especially the case for transcutaneous partial pressure monitoring of oxygen.
Radiometer Basel Ag

Patient monitoring system

A method of determining blood pressure measurements includes inflating a cuff, receiving an indication of pressure inside the cuff during inflation, determining a blood pressure based at least in part on the received indication, assigning a confidence level to the blood pressure, and determining whether the confidence level satisfies a threshold confidence level. Based at least on a determination that the confidence level satisfies a threshold confidence level, the method can include causing a display to display the blood pressure.
Masimo Corporation

Optical blood pressure detection device and operating method thereof

A blood pressure detection method includes the steps of: acquiring a ppg signal from a skin surface using a light sensing element; calculating a blood pressure corresponding to each pulse duration according to at least one pressure estimation model and a time difference between two feature points within one pulse duration; calculating a breathing period; averaging a plurality of blood pressures within the breathing period to generate an average blood pressure; and showing the average blood pressure with a display device.. .
Pixart Imaging Inc.

Method for an accurate automated non-invasive measurement of blood pressure waveform and apparatus to carry out the same

An apparatus for an accurate automated non-invasive measurement of blood pressure waveform using brachial (occlusion) cuff pressurized above systolic pressure and using differential pressure sensor. The methodology involves measurement in suprasystolic mode and in utilization and construction of the device followed by algorithms for processing and analysis of measured blood pressure pulse waves and assessment of hemodynamic parameters of human cardiovascular system.
Czech Technical University In Prague, Czech Institute Of Informatics, Robotics

Ultrasound system for cerebral blood flow imaging and microbubble-enhanced blood clot lysis

An ultrasonic diagnostic imaging system is described which utilizes one or more transducer arrays affixed to the head of a patient to diagnose and treat stroke victims. The transducer headset produces a two or three dimensional image of the vasculature inside the cranium, preferably assisted by a microbubble contrast agent.
Koninklijke Philips N.v.

Stabilization of thrombocytes at ambient temperatures

Provided herein are formulations and methods for the stabilization of one or more thrombocytes at ambient temperatures. Also provided are formulations and methods for the stabilization of one or more thrombocytes in an inactivated state in a blood sample at ambient temperatures.
Biomatrica, Inc.

Biomarkers for human monocyte myeloid0derived suppresor cells

A method for diagnosing an increased risk of a cancer in a subject includes the steps of obtaining a blood sample from the subject and determining, in the blood sample, a level of two or more of the polypeptides selected from the group consisting of vnn2, kcnj15, serpinb2, creb5, icam3, nfe2, mnda, pxn, fcar, tshz3, nrg1, alox5ap, pad14, pad12, qpc, vnn1, serpinb10, clec4d, trem1, clec4e, cd82, mgam, tmem45b and vnn3, wherein an increase in the level of two or more of the polypeptides compared to a control level is indicative of an increased risk of cancer in the subject.. .
Case Western Reserve University

Compositions and methods for fluid biopsy of melanoma

The present invention provides methods for identifying circulating melanoma cells (cmcs) in a biological sample and methods for diagnosing metastatic melanoma in a subject. The methods disclosed can be used on non-enriched blood samples to identify cmc using detectable agents that are specific for a biomarker of cmcs and assessing the morphology of the cells having the detectable agents.
The Scripps Research Institute

Method for monitoring cathepsin s inhibition

C) correlating li p10 peptide level in white blood cells to cathepsin s inhibitor dose, wherein a cathepsin s inhibitor leads to increased level of li p10 peptide in the white blood cells.. .

Constriction-expansion blood plasma separation

A portable, microfluidic blood plasma separation device is presented featuring a constriction-expansion design, which can produce up to about 100% purity for undiluted blood at least about 9% yield. This level of purity represents an improvement of at least one order of magnitude with increased yield compared to that achieved previously using passive separation.
Massachusetts Institute Of Technology

Improvements in using blood culture platforms for commercial sterility tests

A system that indicates the presence or absence of microorganisms in fluid food products. The system has a bottle for receiving sample to be tested.
Becton Dickinson Holdings Pte Ltd.

Transcranial magnetic lesioning of the nervous system for relief of intractable pain

Intractable pain is a horrific cause of world-wide suffering. Nervous system excitation is a hallmark of intractable pain and lesioning of excited pathways and structures can produce sustained analgesia.

System and methods for treating mvo

Mvo is treated by introducing injectate into blood vessels affected by mvo at precise flow rates, while blocking retrograde flow, such that the natural pumping of the heart aids in forcing the injectate into the affected microvessels. Monitoring pressure distal of an occlusion balloon is used to determine treatment effectiveness and heart health..
Reflow Therapeutics Ag

Method for diagnosis and treatment of blood vessel

An introducer having a dilator positioned in a sheath is inserted into a first blood vessel and, thereafter, only the dilator tube is drawn out of the first blood vessel and the sheath while the sheath remains in the first blood vessel. A diagnostic instrument having an outer diameter smaller than a maximum outer diameter permitting insertion into the sheath tube is inserted into the second blood vessel, and a stenosis of the second blood vessel is diagnosed.
Terumo Kabushiki Kaisha

Transvascular access methods

Various methods employing transvascular access devices are described, including a method of placing a central catheter in a peripheral vein in an arm of a patient; a method of providing percutaneous access to the heart of a patient; a method of clearing a clotted arteriovenous dialysis graft; a method of creating multiple access points into a single blood vessel; a method of creating an av fistula in a patient; and a method of providing a bypass to a blockage in a popliteal artery in a patient.. .

Systems and methods for neuromodulation of sympathetic and parasympathetic cardiac nerves

A catheter system configured for delivering a neuromodulation therapy, includes a first therapeutic element positionable in a first target vessel selected from the group of blood vessels consisting of the superior vena cava, left brachiocephalic vein, right brachiocephalic vein, azygos vein or azygos arch, and a second therapeutic element in a second target vessel selected from the group of blood vessels consisting of the superior vena cava, left brachiocephalic vein, right brachiocephalic vein, azygos vein or azygos arch. The system and associated method deliver therapeutic energy to at least one parasympathetic nerve fiber external to the first target vessel using the first therapeutic element, and deliver therapeutic energy to at least one sympathetic nerve fiber external to the second target vessel using the second therapeutic element..
Neurotronik Ip Holding (jersey) Limited

System for optimizing a drug dosage regimen over time

A system for optimizing a patient's basal insulin dosage regimen over time, adapted to determine from blood glucose values whether and by how much to vary a patient's present recommended amount of the insulin-containing drug in order to maintain the patient's future blood glucose level measurements within a predefined range, and wherein a given blood glucose value is disregarded if no patient-actuated operation being indicative of the administration of a dose of an insulin containing drug has been detected in a pre-defined amount of time prior to the determination of the given blood glucose value.. .
Novo Nordisk A/s

Glucagon administration system and methods

Some embodiments a glucagon administration system can provide a suggested glucagon dosage based on one or more particular parameters (e.g., the user's recent blood glucose characteristics, a glucagon sensitivity value of the user, and other parameters). In some circumstances, the glucagon administration system can receive information indicative of the user's blood glucose level and suggest a glucagon dosage that is at least partially dependent upon a previously stored glucagon sensitivity for the user..
Bigfoot Biomedical, Inc.

Fluticasone furoate in the treatment of copd

The present invention relates to pharmaceutical products comprising fluticasone furoate for use in the treatment of copd patients, particularly a subgroup of copd patients that through analysis have been identified as possessing an eosinophil blood count of≧150 cells/w. The present invention is further directed to methods for treating a patient with copd which methods include identifying a patient that will respond to treatment and administering a pharmaceutical product of the present invention comprising fluticasone furoate to said patient..
Glaxosmithkline Intellectual Property Development Limited

Tuneable delivery of nanoparticle bound active plasmin for the treatment of thrombosis

Compositions and methods for therapeutic delivery are disclosed. More particularly, the present disclosure relates to nanoparticle compositions that sequester the activity of a target molecule while leaving other domains accessible to bind targeted tissues of interest.
Indiana University Research And Technology Corporation

Medical device and method

A blood vessel dissecting device method involves inserting a dissecting device into a living body, advancing the dissecting device along a vein, and dissecting the vein and tissue bound to the vein from other surrounding tissue.. .
Terumo Kabushiki Kaisha

Medical device and method

A blood vessel dissecting device method involves inserting a dissecting device into a living body, advancing the dissecting device along a vein, and dissecting the vein and tissue bound to the vein from other surrounding tissue.. .
Terumo Kabushiki Kaisha

Medical device and method

A blood vessel dissecting device method involves inserting a dissecting device into a living body, advancing the dissecting device along a vein, and dissecting the vein and tissue bound to the vein from other surrounding tissue.. .
Terumo Kabushiki Kaisha

Medical device and method

A blood vessel dissecting device method involves inserting a dissecting device into a living body, advancing the dissecting device along a vein, and dissecting the vein and tissue bound to the vein from other surrounding tissue.. .
Terumo Kabushiki Kaisha

Medical device and method

A blood vessel dissecting device method involves inserting a dissecting device into a living body, advancing the dissecting device along a vein, and dissecting the vein and tissue bound to the vein from other surrounding tissue.. .
Terumo Kabushiki Kaisha

Device for recanalization of vessel occlusions using guide wire and use

An attachment mechanism and method for attaching or coupling a guide wire to a catheter for re-canalization or opening a passage through an occlusion in a blood vessel is provided. The attachment mechanism generates friction forces against the guide wire to couple the guide wire to a catheter, which design permits a greater force to be used on the guide wire during a re-canalization procedure.
Medinol Ltd.

Device and treating vascular occlusion

A system and method for managing an occlusion, such as a blood clot, within a lumen or passageway of a patient. More particularly, a system and method for rapidly restoring blood flow through an occlusion including a self-expanding, tubular member through which blood may flow when in an expanded state.
Inceptus Medical, Llc

Methods and devices for treating stroke

Methods and devices are disclosed herein that allow for infusion and aspiration through a single device. The device can be used to treat a stroke by delivering the device to the site of a blood clot and simultaneously or sequentially infusing a thrombolytic or other drug into the clot and aspirating the dissolving clot from the patient.
Alcyone Lifesciences, Inc.

Combined floormat and body-worn physiological sensors

The invention provides systems for measuring blood pressure and stroke volume values from a patient. Both systems feature a floormat system and a body-worn sensor working in concert.
Tosense, Inc.

Evaluating multivariate response of circadian rhythms

A statistical system is disclosed to analyze multivariate response of circadian rhythms in a crossover design, in which response variables are continuously monitored to evaluate the therapeutic effect of a regimen on circadian rhythms such as blood pressure and blood sugar. The methods determine the alteration of not only amplitude but also correlation of multiple circadian rhythms under the influence of a regimen..

Physiological monitoring system featuring floormat and handheld sensor

The invention described herein is a system that features a floormat and handheld sensor that operate in concert with a user's mobile device. The floormat resembles a conventional bathroom scale, but features an enhanced set of measurements that include pulse rate and/or heart rate, spo2, respiratory rate, weight, body composition, and fluids.
Tosense, Inc.

Physiological monitoring system featuring floormat and handheld sensor

The invention described herein is a system that features a floormat and handheld sensor that operate in concert with a user's mobile device. The floormat resembles a conventional bathroom scale, but features an enhanced set of measurements that include pulse rate and/or heart rate, spo2, respiratory rate, weight, body composition, and fluids.
Tosense, Inc.

Physiological monitoring system featuring floormat and handheld sensor

The invention described herein is a system that features a floormat and handheld sensor that operate in concert with a user's mobile device. The floormat resembles a conventional bathroom scale, but features an enhanced set of measurements that include pulse rate and/or heart rate, spo2, respiratory rate, weight, body composition, and fluids.
Tosense, Inc.

Combined floormat and body-worn physiological sensors

The invention provides systems for measuring blood pressure and stroke volume values from a patient. Both systems feature a floormat system and a body-worn sensor working in concert.
Tosense, Inc.

Floormat physiological sensor

A stand-on physiological sensor (e.g. Floormat) measures vital signs and various hemodynamic parameters, including blood pressure and ecg waveforms.
Tosense, Inc.

Floormat physiological sensor

A stand-on physiological sensor (e.g. Floormat) measures vital signs and various hemodynamic parameters, including blood pressure and ecg waveforms.
Tosense, Inc.

Floormat physiological sensor

A stand-on physiological sensor (e.g. Floormat) measures vital signs and various hemodynamic parameters, including blood pressure and ecg waveforms.
Tosense, Inc.

Floormat physiological sensor

A stand-on physiological sensor (e.g. Floormat) measures vital signs and various hemodynamic parameters, including blood pressure and ecg waveforms.
Tosense, Inc.

Floormat physiological sensor

A stand-on physiological sensor (e.g. Floormat) measures vital signs and various hemodynamic parameters, including blood pressure and ecg waveforms.
Tosense, Inc.

Floormat physiological sensor

A stand-on physiological sensor (e.g. Floormat) measures vital signs and various hemodynamic parameters, including blood pressure and ecg waveforms.
Tosense, Inc.

Physiological monitoring system featuring floormat and handheld sensor

The invention described herein is a system that features a floormat and handheld sensor that operate in concert with a user's mobile device. The floormat resembles a conventional bathroom scale, but features an enhanced set of measurements that include pulse rate and/or heart rate, spo2, respiratory rate, weight, body composition, and fluids.
Tosense, Inc.

Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis

Systems and methods are disclosed for non-invasively measuring blood glucose levels in a biological sample based on spectral data. This includes at least one light source configured to strike a target area of a sample, at least one light detector positioned to receive light from the at least one light source and to generate an output signal, having a time dependent current, which is indicative of the power of light detected, a processor configured to receive the output signal from the at least one light detector based on the received output signal, calculate the attenuance attributable to blood in a sample present in the target area with a ratio factor, eliminate effect of uncertainty caused by temperature dependent detector response of the at least one light detector, and then determine a blood glucose level associated with a sample present in the target area based on the calculated attenuance with the processor..
St. Louis Medical Devices, Inc.

Physiological monitoring system featuring floormat and handheld sensor

The invention described herein is a system that features a floormat and handheld sensor that operate in concert with a user's mobile device. The floormat resembles a conventional bathroom scale, but features an enhanced set of measurements that include pulse rate and/or heart rate, spo2, respiratory rate, weight, body composition, and fluids.
Tosense, Inc.

Floormat physiological sensor

A stand-on physiological sensor (e.g. Floormat) measures vital signs and various hemodynamic parameters, including blood pressure and ecg waveforms.
Tosense, Inc.

Floormat physiological sensor

A stand-on physiological sensor (e.g. Floormat) measures vital signs and various hemodynamic parameters, including blood pressure and ecg waveforms.
Tosense, Inc.

Devices and methods for noninvasive measurement of intracranial pressure

Provided are systems and methods for noninvasively assessing intracranial pressure by controllably osculating at least a portion of a subject's ocular globe while applying a force sufficient to collapse an intraocular blood vessel and correlating the collapse pressure to intracranial pressure. Also provided are ophthalmic components useful in ophthalmic imaging applications, such as retinal, corneal, and pupil imaging.

Illuminated blood pressure cuff

A blood pressure gauge for monitoring the blood pressure values of a patient in a darkened or low light environment. The blood pressure gauge is selectively illuminated when an internal air pressure within an attached blood pressure cuff is first detected or after it has reached a predetermined threshold value as determined by a pressure transducer in the blood pressure gauge.
Care 2 Innovations, Inc.

Floormat physiological sensor

A stand-on physiological sensor (e.g. Floormat) measures vital signs and various hemodynamic parameters, including blood pressure and ecg waveforms.
Tosense, Inc.

Floormat physiological sensor

A stand-on physiological sensor (e.g. Floormat) measures vital signs and various hemodynamic parameters, including blood pressure and ecg waveforms.
Tosense, Inc.

Combined floormat and body-worn physiological sensors

The invention provides systems for measuring blood pressure and stroke volume values from a patient. Both systems feature a floormat system and a body-worn sensor working in concert.
Tosense, Inc.

Combined floormat and body-worn physiological sensors

The invention provides systems for measuring blood pressure and stroke volume values from a patient. Both systems feature a floormat system and a body-worn sensor working in concert.
Tosense, Inc.

Detecting leakage when heating a perishable dielectric load

A cartridge holds a perishable dielectric load, e.g. blood plasma, during heating n a heating chamber by means of an electromagnetic field from an emitting element.
Antrad Medical Ab

Glucose meter with alarm

A glucose meter with an adjustable alarm and an integral wireless transmitter to send a user a reminder to take a second glucose level measurement. The glucose meter with an alarm features a housing with a display and input buttons connected to a microprocessor.

Methods and system for hemorrhage-specific determinations

Methods and a system are provided for assessing postpartum hemorrhage risk and postpartum hemorrhage stages in a clinical setting. Generally, a clinician may indicate that the mass of several bloody items, indicated in type and quantity, is to be measured using a scale.
Cerner Innovation, Inc.

Wearable continuous blood glucose monitoring

A system, a method, and a computer program product for providing wearable continuous blood glucose monitoring. In some embodiments, there is provided a method that includes receiving, at a smartwatch, an alert representative of a glucose state of a host-patient coupled to a glucose sensor; detecting, at the smartwatch, a predetermined action indicative of a request to generate a glance view providing an indication of the glucose state of the host-patient; and presenting, at the smartwatch and in response to the detecting, the glance view providing the indication of the glucose state of the host-patient..
Dexcom, Inc.

Wearable continuous blood glucose monitoring

A system, a method, and a computer program product for providing wearable continuous blood glucose monitoring. In some embodiments, there is provided a method that includes receiving, at a smartwatch, an alert representative of a glucose state of a host-patient coupled to a glucose sensor; detecting, at the smartwatch, a predetermined action indicative of a request to generate a glance view providing an indication of the glucose state of the host-patient; and presenting, at the smartwatch and in response to the detecting, the glance view providing the indication of the glucose state of the host-patient..
Dexcom, Inc.

Diagnostics

The present invention relates to the detection or diagnosis of infection or inflammation in a patient. In particular, the invention provides methods that allow the detection of markers in a sample from a patient or subject, such as a blood sample, which will indicate whether the patient or subject has an infection or has an inflammatory response..
Ucl Business Plc

Methods for determining whether a patient will achieve a response after radiation therapy

Disclosed are methods for determining whether a patient will achieve a response after radiation therapy, in particular a method for determining whether a patient suffering from a cancer will achieve a response after radiation therapy including the steps of i) determining the level of ceramide in a first blood sample obtained from the patient before radiation therapy, ii) determining the level of ceramide in a second blood sample obtained from the patient during or just after radiation therapy, iii) comparing the level determined at step i) with the level determined at step ii) and iv) concluding that the patient will achieve response when the level determined at step ii) is higher than the level determined at step i) or concluding that the patient will not achieve a response when the level determined at step ii) is lower than the level determined at step i).. .
Institut De Cancerologie De L'ouest - Site Rene Gauducheau

Hypoglycemic agent containing anti-ang2 antibody

Provided is a method of decreasing blood sugar level or preventing and/or treating a hyperglycemia-related disease, including administering an anti-ang2 antibody or an antigen-biding fragment thereof to a subject in need thereof.. .
Samsung Electronics Co., Ltd.

Method and appratus for treatment of intracranial hemorrhages

An ultrasound catheter with a lumen for fluid delivery and fluid evacuation, and an ultrasound source is used for the treatment of intracerebral or intraventricular hemorrhages. After the catheter is inserted into a blood clot, a lytic drug can be delivered to the blood clot via the lumen while applying ultrasonic energy to the treatment site.
Ekos Corporation

Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache, and pain control, asthma, angina, hypertension, depression, cold, flue and the like

Systems and methods for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and treating hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, attention deficit disorder and nicotine addiction involve synchronizing and tailoring the administration of nutraceuticals, medications and other substances in accordance with the body's natural circadian rhythms, meal times and other factors. Improved control of blood glucose levels, extended alertness, and weight control, and counteracting of disease symptoms when they are at their worst are possible.

Optical detection of lipids

blood separation systems and methods are provided for detecting lipids in plasma that has been separated from a plasma-containing fluid, such as blood. The system includes a fluid processing region in which a plasma-containing fluid is separated into plasma and other fluid components.
Fenwal, Inc.

Agent for preventing or ameliorating diabetes

An object of the present invention is to find a component that is safe and is capable of effectively exerting various effects such as prevention or amelioration of diabetes, prevention or amelioration of metabolic syndrome, amelioration of insulin resistance, inhibition of an increase in a postprandial blood sugar level, and inhibition of α-glucosidase activity. The present invention provides agents for preventing or ameliorating diabetes or the like, the agents including a component of a hybrid plant of camellia sinensis and camellia taliensis as an active ingredient.
Kyushu University National University Corporation

Fermented food extract composition

Provided is a fermented food extract that has a blood pressure-lowering action and is useful as a functional health food or pharmaceutical composition. This fermented food extract is obtained by: subjecting a fermented food, preferably a fermented fagopyrum esculentum lyophilisate, to acetone extraction; eluting the fermented fagopyrum esculentum acetone extract using a solid phase extract cartridge filled with a resin to which a phenyl group is bonded, with formic acid-containing water used as an eluent; and fractionating and purifying the eluate using a column (pfp column) filled with a carrier to which a pentafluorophenyl group is bonded, with formic acid/methanol-containing water used as a mobile phase.
Shinshu University





Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Blood for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Blood with additional patents listed. Browse our RSS directory or Search for other possible listings.


2.3493

file did exist - 12516

2 - 1 - 251